Category: PSYCH STOCK NEWS

Mycotopia Therapies (TPIA) $1.65, Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021

Mycotopia Therapies looking to unlock the full potential of psychedelic-derived medicines; Create Active Pharmaceutical Ingredient (API) for magic mushroom MIAMI, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mycotopia...

Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic Company.

Conference Call Today at 12:00 EST. As the TSX chart above show, investors appear to be warming up the the idea. Not many investors...

Mindcure (MCURF) and Awakn Life Sciences (AWKNF) Seek to Distribute Ketamine Protocol for Alcohol Use Disorder.

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE's Digital Therapeutics Platform

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr. Sharmin Ghaznavi. Recent Wall Street...

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most. The Psychedelic Renaissance is roaring. Over the past...

Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on Good Morning America.

News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment for curb substance abuse addictions.

Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the United Kingdom

Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq Capital Market on September 15, 2021, under the...

Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida

"I believe that we are on the verge of curing, as opposed to simply treating, certain psychiatric maladies." Dr. Jeffrey Kamlet, Chief Medical Officer of Ehave.
Most Popular

1000 Days Without Alcohol: Here’s What Happened

No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...

Non-Hallucinogenic Psychedelics or Short Term vs Long Term Acting Psychedelics, Which are Best.

Great Interview with Adam Tubero, Jake Slomowitz and Steve McCraken, Analyst's who Drink the Kool Aide for...